PropertyValue
?:definition
  • Immunoassay reagents intended to perform quantitative analyses on a body fluid sample (e.g., serum, plasma, whole blood) to measure levels of one or more of a group of therapeutic drugs known as \'anticonvulsants\' (i.e., drugs intended to prevent seizures [clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells] or reduce their severity, or to treat related central nervous system disorders) present in the sample. These reagents are mostly used to measure drug levels in patients undergoing treatment with anticonvulsant agent to determine the adequacy of drug treatment or to diagnose a drug overdose or drug-related toxicity.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C3691471_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C3691471_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all